
Enable job alerts via email!
Generate a tailored resume in minutes
Land an interview and earn more. Learn more
A leading global pharmaceutical organization seeks a Global RWE & Health Outcomes Research Analyst to support evidence generation strategies. Your role will involve collaborating across functions, managing data generation plans, and overseeing non-interventional studies. Candidates should have an MSc in relevant fields and experience in the pharmaceutical industry. This position offers a chance to contribute to significant projects in a high-visibility environment.
Location: Homebased / Hybrid
Sector: Pharmaceutical / Biotechnology
CY Partners is partnering with a leading global pharmaceutical organisation to recruit a Global Real-World Evidence (RWE) & Health Outcomes Research (HOR) Analyst / Epidemiologist. This role sits within a mature, globally integrated RWE & HOR function and supports a strategic, late-stage / marketed priority asset across its lifecycle.
This opportunity is well suited to candidates with hands‑on experience working in, or closely with, the pharmaceutical industry, who are looking to deepen their impact in global evidence generation.
Reporting directly to the Global RWE & HOR Lead, you will contribute to the development and execution of asset‑level real‑world evidence strategies aligned to regulatory, access, and medical needs. You will work cross‑functionally within a complex global matrix, collaborating closely with Medical Affairs, HEOR, Clinical Development, Market Access, and external research partners.
MSc (or equivalent) in a relevant discipline, such as:
Demonstrable experience within the pharmaceutical or biotechnology industry, or in a consultancy/CRO supporting pharma clients
Practical experience delivering RWE and/or non‑interventional studies in an industry setting
Familiarity with regulatory, HTA, or payer evidence expectations
Strong ability to operate within global, cross‑functional matrix teams
Excellent stakeholder management and scientific communication skills
This is an opportunity to work on a high‑visibility global asset, contribute to evidence that directly informs regulatory, access, and medical strategy, and grow your career within a best‑in‑class pharmaceutical RWE & HEOR function.
For more information or a confidential discussion, please contact CY Partners